An official website of the United States Government —

Here’s how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

GAO makes MedPAC commissioner appointments:

Click here for more information.

Advising the Congress on Medicare issues
MedPAC > Recommendations

Commission Recommendations

MedPAC makes recommendations to the Congress and to the Secretary of Health and Human Services on issues affecting the administration of the Medicare program. With its recommendations, the Commission strives to improve the delivery of care, while ensuring financial stability and maximizing value for the program. After extensive analysis and evaluation, our recommendations are discussed and voted on by Commissioners in our public meetings. Recommendations are typically published in two main reports, released in March and June of each year.

Recommendations Topic(s) Publication

Increasing participation in the Medicare Savings Programs and the low-income drug subsidy (3)

The Congress should change program requirements so that the Social Security Administration screens low-income drug subsidy applicants for federal Medicare Savings Program eligibility and enrolls them if they qualify.

  • Beneficiaries and coverage
  • Drugs, Devices, and Tests

March 2008 - Chapter 5

Part D enrollment, benefit offerings, and plan payments

The Congress should direct the Secretary to make Part D claims data available regularly and in a timely manner to congressional support agencies and selected executive branch agencies for purposes of program evaluation, public health, and safety.

  • Drugs, Devices, and Tests

March 2008 - Chapter 4

Issues in Medicare coverage of drugs (A)

The Congress should direct CMS to identify selected overlap drugs and direct plans to always cover them under Part D. Identified drugs should be: * Low cost * Covered under Part D most of the time.

  • Drugs, Devices, and Tests

June 2007 - Chapter 7

Issues in Medicare coverage of drugs (B)

The Congress should allow plans to cover a transitional supply of overlap drugs under Part D under the same conditions as the general transition policy applied by CMS.

  • Drugs, Devices, and Tests

June 2007 - Chapter 7

Issues in Medicare coverage of drugs (C)

The Congress should permit coverage for appropriate preventive vaccines under Medicare Part B instead of Part D.

  • Beneficiaries and coverage
  • Drugs, Devices, and Tests

June 2007 - Chapter 7

Monitoring the implementation of Part D

The Secretary should have a process in place for timely delivery of Part D data to congressional support agencies to enable them to report to the Congress on the drug benefit’s impact on cost, quality, and access.

  • Drugs, Devices, and Tests

June 2005 - Chapter 1

Payment for pharmacy handling costs in hospital outpatient departments (A)

The Secretary should establish separate, budget-neutral payments to cover the costs that hospitals incur for handling separately paid drugs, biologicals, and radiopharmaceuticals.

  • Drugs, Devices, and Tests
  • Hospital

June 2005 - Chapter 6

Payment for pharmacy handling costs in hospital outpatient departments (B)

The Secretary should: * Define a set of handling fee APCs that group drugs, biologicals, and radiopharmaceuticals based on attributes of the products that affect handling costs; * Instruct hospitals to submit charges for those APCs; and * Base payment rates for the handling fee APCs on submitted charges, reduced to costs.

  • Drugs, Devices, and Tests
  • Hospital

June 2005 - Chapter 6

Strategies to improve care: Pay for performance and information technology (G)

CMS should ensure that the prescription claims data from the Part D program are available for assessing the quality of pharmaceutical and physician care.

  • Drugs, Devices, and Tests

March 2005 - Chapter 4

Payment for new technologies in Medicare’s prospective payment systems

The Secretary should introduce clinical criteria for eligibility of drugs and biologicals to receive pass-through payments under the outpatient prospective payment system.

  • Drugs, Devices, and Tests
  • Hospital

March 2003 - Chapter 4